Release: Schweikert Votes Against Capping Insulin Prices

March 31, 2022

Release

March 31, 2022

Contact: Matt Grodsky
[email protected]
602.432.6889

Website: gingerforarizona.com

Release: Schweikert Votes Against Capping Insulin Prices

PHOENIX -  Today, the Democratic-controlled House passed historic legislation that will cap consumers’ out-of-pocket cost for insulin at $35 per month.

There are nearly 30 million Americans diagnosed with diabetes, and for the millions who require insulin, the prescription drug often makes the difference between life and death. Studies have found that nearly a quarter of diabetes patients alarmingly have been forced to ration or skip their medication due to soaring prices.

That appeared not to matter to Rep. David Schweikert who today, once again, chose to undermine his constituents by voting against legislation that would help Americans afford the drug that keeps them alive.

David Schweikert has let down the voters who have entrusted him to do the right thing. Luckily, in November, voters will have an opportunity to elect a real leader who will prioritize the will of Arizona voters -- not special interest groups. That leader is Ginger Sykes Torres, who today made the following statement: 

"It sickens me that someone who was elected to improve the lives of Arizonans would so willingly vote against their best interests. Insulin is a vital medication for thousands of Arizonans of all ages. Nobody in their right mind would vote against keeping prices for this precious prescription drug under control. In Congress, I won't bow to big pharma. I will stand up for Arizonans and make sure prescription medication is accessible and affordable."

 
###